REFERENCES
- Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Reviews of Infectious Diseases 1987; 9(Suppl. 1)S57–S63
- Granade T.C., Artis W.M. Antimycotic susceptibility testing of dermatophytes in micro-cultures with a standardized fragmented mycelial inoculum. Antimicrobial Agents and Chemotherapy 1980; 17: 725–729
- Heel R.C. Ketoconazole: pharmacological profile. In vitro and in vivo activity. Ketoconazole in the Management of Fungal Disease, H.B. Levine. ADIS Press, New York 1982; 57–66, In
- Mahgoub E.S., Gumaa S.A. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Transactions of the Royal Society of Tropical Medicine and Hygiene 1984; 78: 376–379
- Van Cutsem J., Van Gerven F., Janssen P.A.J. Activity of orally, topically and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Reviews of Infectious Diseases 1987; 9(Suppl. 1)S15–S32
- Venugopal P.V., Venugopal T.V., Laing W.N., Al Humaidan Y., Namnyak S.S., AlJama A.A., El Bashier A.M. Black grain mycetoma caused by Madurella grisea in Saudi Arabia. International Journal of Dermatology 1990; 29: 434–435
- Venugopal P.V., Venugopal T.V., Laing W.N., Namnyak S.S., Humaidan Y.A., ElBashier A.M., Al Jama A.A. Scalp mycetomas in Saudi Arabia. International Journal of Dermatology 1991; 30: 602–602